Business
AstraZeneca expects COVID variant vaccine by mid to late 2021 – Al Jazeera English
The drug company says it expects an updated COVID-19 vaccine targeting new variants to be ready for use this year.
AstraZeneca has said it expects to have a new version of its COVID-19 vaccine ready for use by mid to late 2021, responding to concerns about emerging variants of the disease that may be more transmissible or resistant to existing vaccines.
The Anglo-Swedish company, which makes a vaccine developed by the University of Oxford, said on Thursday that researchers began the work on the updates months ago when the new variants were first detected.
Were moving fast and weve got a number of variant versions…
-
Business24 hours agoMacquarie increases price target for Qantas shares
-
Business22 hours agoWhy Auckland Airport, Australian Ethical, Breville, and Clarity shares are charging higher
-
Noosa News24 hours agoHoyts Is Set to Launch Up to Five New IMAX Screens in Australia — Including at Melbourne Central Before the End of 2025
-
Noosa News22 hours agoCommonwealth Bank executive Christopher James McCann found dead in Springbrook National Park